Skip to main content

Posts

Featured

Spiriva Respimat Approved for maintenance of COPD

"Boehringer Ingelheim announced that the US regulatory body has approved Spiriva Respimat (tiotropium bromide) inhalation spray for the long-term, once-daily maintenance treatment of bronchospasm associated with chronic obstructive pulmonary disease (COPD)." According to the Pharmaceutical Journal, Spiriva Respimat (tiotropium bromide monohydrate; Boehringer Ingelheim) is now recommended as an add-on preventive therapy. It is for adult asthma patients currently being treated with a maintenance combination of inhaled corticosteroids and long-acting β2 agonists who already had one or more serious exacerbations in the previous year. Spiriva Respimat releases a pre-measured dosage in a slow-moving spray, irrespective of how easily air from the inhaler is breathed in. The Respimat inhaler creates the slow-moving mist through mechanical energy. Spiriva Respimat solution uses the same element as Spiriva HandiHaler (inhalation material for tiotropium bromide) as stated by MPR

Latest posts